NM Magazine · Mar 2026
Profiles Sandeep Dave and notes that Data-Driven Bioscience, now Duoseq, provides DNA and RNA sequencing of patient samples within 48 hours.
Cancer Diagnosis 10X faster, 10X cheaper
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Data Driven Bioscience (operating as Duoseq) is a Durham-based cancer genomics company that sells a dual DNA/RNA profiling assay and software-enabled workflow for faster clinical cancer diagnosis.
Primary product
Duoseq, an all-in-one dual DNA/RNA cancer profiling assay and reporting workflow
Founded
2018
Headquarters
701 West Main Street, Durham, NC 27701, United States
Team size
7-10
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
Cancer genomics / clinical diagnostics
Offices
701 West Main Street, Durham, NC 27701, United States
Durham, North Carolina, United States
Business model
B2B clinical diagnostics
kitted assay + software workflow
bioinformatics-enabled lab platform
enterprise/lab services
Funding
People & investors
Work & culture
Mission-driven, interdisciplinary, research-heavy, and focused on speeding cancer diagnosis with software and genomics.
Work style
Flexible
Compensation
Public job copy says the company pays a very competitive salary and offers stock ownership; no public salary bands were found.
Benefits
competitive salary
stock ownership
remote work okay
Product & market
Pricing
Not publicly disclosed; appears to be B2B clinical assay / software workflow sales to labs, hospitals, and biopharma customers.
Differentiators
- —Dual DNA and RNA profiling from a single sample
- —Two-day sample-to-report turnaround
- —On-site processing avoids shipping delays
- —EPIC/EHR integration for automated reporting
- —Designed for robotic workflows with under 10 minutes of technician time
- —Regulatory and MolDX support
Technology
dual DNA/RNA sequencing
EPIC/EHR integration
on-site sample processing
robotic workflow compatibility
cloud-based machine-learning software
bioinformatics reporting
Customers
pathologists
oncologists
biopharmaceutical companies
clinical labs
hospitals
pharmaceutical companies
Competitors
Qiagen
Neogen
Sino Biological
Parse Biosciences
Biofidelity
Scale & contact
Estimated revenue
≈$1.5M ARR (estimate)
Latest news
Scholars@Duke · Jan 2026
Research publication summarizing Duoseq’s clinical validation in blood cancers.
Journal of Molecular Diagnostics · Oct 2025
Reports clinical validation of Duoseq as a genomic profiling tool for blood cancers, including accuracy and turnaround details.
HigherGov · Jan 2025
Shows a federal grant award in January 2025 and confirms Durham HQ, February 2018 founding, and NAICS 541715.
TechCrunch · Aug 2018
Original launch coverage describing the company’s faster, cheaper cancer diagnosis pitch and founder Sandeep Dave.
Jobs and careers at Data Driven Bioscience
0 jobs at Data Driven Bioscience
No open positions
Check back later for new openings